International Journal of Clinical Research

Objective To analyze the value of serum Cystatin C (CysC) and blood coagulation function test in patients with acute cerebral infarction (ACI). Methods 50 ACI patients admitted from August 2020 to September 2021 were selected as the observation group, and 50 healthy individuals who underwent physical examinations during the same period were selected as the control group. CysC and coagulation function tests were performed on both groups, and the test results of the two groups and patients with different infarction types and prognosis were compared. Results The FIB and CysC levels in the observation group/complete/death group were higher than those in the control group/progressive/survival group (P<0.05); The APTT, TT, and PT levels in the observation group/complete/death group were lower than those in the control group (P<0.05); Among the factors that affect coagulation function and CysC levels, prognosis and disease type are independent risk factors (P<0.05). Conclusion The effectiveness of using CysC and coagulation function to diagnose ACI patients is good, which can provide valuable evidence for physicians in evaluating and analyzing the condition and prognosis.

Coagulation function; Diagnostic value; Acute cerebral infarction; Serum Cystatin C; Prognosis